Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.73 USD | +5.51% | +6.80% | -7.23% |
Apr. 19 | Xenon Pharmaceuticals Inc. Announces Board Resignations | CI |
Mar. 11 | Transcript : Xenon Pharmaceuticals Inc. Presents at Leerink Partners Global Biopharma Conference 2024, Mar-11-2024 11:20 AM |
Business Summary
Number of employees: 255
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ian Mortimer
CEO | Chief Executive Officer | 48 | 13-10-20 |
Simon Pimstone
FOU | Founder | 56 | 96-11-04 |
Sherry Aulin
DFI | Director of Finance/CFO | 40 | 10-12-31 |
Chief Tech/Sci/R&D Officer | - | 21-08-22 | |
Sheila M. Grant
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-31 |
Jodi Regts
IRO | Public Communications Contact | - | 15-11-30 |
Corporate Officer/Principal | - | 20-08-16 | |
Andrea DiFabio
LAW | General Counsel | 55 | 22-11-06 |
James Empfield
PRN | Corporate Officer/Principal | - | 16-01-31 |
Corporate Officer/Principal | 63 | 01-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Clarence Machado
BRD | Director/Board Member | 60 | 20-11-04 |
Mohammad Azab
BRD | Director/Board Member | 68 | 03-09-30 |
Justin Gover
BRD | Director/Board Member | 53 | 23-08-07 |
Gary Patou
BRD | Director/Board Member | 65 | 03-12-31 |
Simon Pimstone
FOU | Founder | 56 | 96-11-04 |
Steven Gannon
BRD | Director/Board Member | 62 | 15-05-20 |
Ian Mortimer
CEO | Chief Executive Officer | 48 | 13-10-20 |
Dawn Svoronos
BRD | Director/Board Member | 70 | 16-09-26 |
Director/Board Member | 66 | 21-06-02 | |
Gillian Cannon
BRD | Director/Board Member | 60 | 23-08-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 75,432,482 | 74,047,334 ( 98.16 %) | 0 | 98.16 % |
Company contact information
Xenon Pharmaceuticals, Inc.
3650 Gilmore Way Suite 200
V5G 4W8, Burnaby
+604 484 3300
http://www.xenon-pharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.73% | 3.06B | |
-2.37% | 103B | |
+1.78% | 95.28B | |
+1.46% | 22.15B | |
-15.66% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.91% | 16.05B | |
+5.34% | 13.68B | |
+35.67% | 12.17B |
- Stock Market
- Equities
- XENE Stock
- Company Xenon Pharmaceuticals Inc.